Following a quarter in which sales of its sera products declined sharply, Invitrogen officials said last week that they are reviewing the firm’s entire portfolio with a particular focus on the sera business.
Additionally, though the officials declined to say whether a divestment of that business was possible, Chairman and CEO Greg Lucier said the firm is currently reviewing whether “we need to be broadly in the sera business” and hopes to know more in six months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.